Subscription figures for the Mahamaya Lifesciences SME IPO, by investor category and by day, as published by the exchanges.
| Category | Shares offered | Shares bid | Times |
|---|---|---|---|
| Individual | 20,59,200 | 21,07,200 | 1.02× |
| NIIs | 11,91,600 | 35,14,800 | 2.95× |
| BNIIs (>10L) | 5,88,000 | 32,50,800 | 5.53× |
| SNIIs (<10L) | 2,94,000 | 2,64,000 | 0.90× |
| QIBs | 11,76,000 | 14,01,600 | 1.19× |
Cumulative bids from the BSE and NSE public-issue platforms. The anchor portion is allotted the day before the issue opens and is not part of the book.
| Day | Retail | Total |
|---|---|---|
| Day 1 (11 November 2025) | 0.07× | 0.11× |
| Day 2 (12 November 2025) | 0.20× | 0.34× |
| Day 3 (13 November 2025) | 1.02× | 1.59× |
Figures appear once the issue opens and the exchanges publish the first day's bids.
Not yet known; the first figures arrive on the opening day.
Qualified institutional buyers are mutual funds, insurers, banks and foreign institutions. Non-institutional investors, also called HNI, are individuals and bodies bidding above two lakh rupees, split into small (two to ten lakh) and big (above ten lakh). Retail is an individual bidding up to two lakh rupees. An SME issue sets aside at least 35 percent of the offer for retail and 15 percent for NII after the market maker's portion.
No. Subscription measures demand during the three bidding days; the listing price is discovered in the pre-open session on listing morning and depends on the market that day. Heavily subscribed issues have listed at a discount and thin ones at a premium. Read the figure with the expected premium and the company's numbers, not instead of them.
14 November 2025. The allotment status is searchable by PAN on Rupix and on the registrar's page from that evening.